Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the briefHow this story developed
4 reports over 3 days-
CNBC Top Stories Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market Neutral 0
-
New York Times Business You're reading this Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion Neutral 0
-
CNBC Business Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says Neutral 0
More like this






